Skip to main contentUnresolvableMixed ResultPlaintiff WinDefendant WinDefendant Win
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S
U.S. Supreme CourtNovember 7, 2011No. No. 10-844
Mixed ResultNovo Nordisk A/S
Case Details
- Status
- Published
- Procedural Posture
- Supreme Court affirmed in part, reversed in part regarding Federal Circuit decision on patent law and pharmaceutical regulatory procedures
- Circuit
- Federal Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The Supreme Court affirmed in part and reversed in part the Federal Circuit's decision regarding patent law and pharmaceutical regulatory procedures under the Hatch-Waxman Act.
Similar Rulings
Jean Adams v. Novo Nordisk A/S
9th CircuitMar 2022
Novo Nordisk A/s v. Caraco Pharmaceutical Laboratories, Ltd.
Federal CircuitMay 2012
Caraco Pharm.
U.S. Supreme CourtApr 2012
Metabolite Laboratories, Inc. And Competitive Technologies, Inc. v. Laboratory Corporation of America Holdings (Doing Business as Labcorp)
Federal CircuitJun 2004
Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc.
U.S. Supreme CourtJun 2006
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.